|
There was an allegation of questionable triglycerides, bilirubin total gen.3, uric acid ver.2, and calcium gen.2 results for 2 patient samples on a cobas c 111 analyzer module.On (b)(6) 2025, patient 1 had an initial total bilirubin result of 19.4 umol/l and a triglycerides result of 4.61 mmol/l from another laboratory.The sample was repeated on the customer's c111 analyzer and the total bilirubin result was 14.3 umol/l and the triglycerides result was 3.15 mmol/l.On (b)(6) 2025, a sample for patient 2 was repeated 8 times on the c111 analyzer.On (b)(6) 2025, the sample had total bilirubin results of 29.8 umol/l, 28.8 umol/l, 28.8 umol/l, and 29.3 umol/l.On (b)(6), the sample had results of 37.8 umol/l, 35.4 umol/l, 35.4 umol/l, and 35.4 umol/l.On (b)(6) 2025, the sample had uric acid results of 278.0 umol/l, 279.3 umol/l, 282.8 umol/l, and 281.7 umol/l.On (b)(6), the sample had results of 365.2 umol/l, 337.3 umol/l, 356.7 umol/l, and 348.4 umol/l.On (b)(6), the sample had calcium results of 2.29 mmol/l, 2.32 mmol/l, 2.32 mmol/l, and 2.32 mmol/l.On (b)(6), the sample had results of 2.92 mmol/l, 2.71 mmol/l, 2.83 mmol/l, and 2.83 mmol/l.
|